tretazicar has been researched along with Cancer of Head in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dexter, MT; Djeha, AH; Hulme, A; Kerr, DJ; Mountain, A; Searle, PF; Wrighton, CJ; Young, LS | 1 |
| Djeha, AH; Harris, PA; Kerr, DJ; Leung, H; Mountain, A; Searle, PF; Thomson, TA; Wrighton, CJ; Young, LS | 1 |
2 other study(ies) available for tretazicar and Cancer of Head
| Article | Year |
|---|---|
Expression of Escherichia coli B nitroreductase in established human tumor xenografts in mice results in potent antitumoral and bystander effects upon systemic administration of the prodrug CB1954.
Topics: Animals; Apoptosis; Aziridines; Carcinoma, Hepatocellular; Carcinoma, Squamous Cell; Cross-Linking Reagents; Dose-Response Relationship, Drug; Escherichia coli; Head and Neck Neoplasms; Humans; Immunohistochemistry; Liver Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Necrosis; Neoplasm Transplantation; Neoplasms, Experimental; Nitroreductases; Prodrugs; Remission Induction; Time Factors; Tumor Cells, Cultured | 2000 |
Combined adenovirus-mediated nitroreductase gene delivery and CB1954 treatment: a well-tolerated therapy for established solid tumors.
Topics: Adenoviridae; Animals; Antineoplastic Agents; Aziridines; Carcinoma, Hepatocellular; Colorectal Neoplasms; Dose-Response Relationship, Drug; Escherichia coli; Gene Transfer Techniques; Genetic Therapy; Head and Neck Neoplasms; Humans; Liver Neoplasms; Luciferases; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Nitroreductases; Prodrugs; Prostatic Neoplasms; Transduction, Genetic; Transfection; Tumor Cells, Cultured | 2001 |